Gene · 23345
Papers2,274
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
381 to 400 of 2,274
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Cuproptosis-Related LncRNA-Based Prediction of the Prognosis and Immunotherapy Response in Papillary Renal Cell Carcinoma. | Int J Mol Sci | 2023 | 36674979 | PubTator, text mining | PubMed |
| Chromatin and Cancer: Implications of Disrupted Chromatin Organization in Tumorigenesis and Its Diversification. | Cancers (Basel) | 2023 | 36672415 | PubTator, text mining | PubMed |
| Cross-ancestry genome-wide analysis of atrial fibrillation unveils disease biology and enables cardioembolic risk prediction. | Nat Genet | 2023 | 36653681 | PubTator, text mining | PubMed |
| Activated Mast Cells Combined with NRF2 Predict Prognosis for Esophageal Cancer. | J Oncol | 2023 | 36644231 | PubTator, text mining | PubMed |
| Single-cell gene regulatory network prediction by explainable AI. | Nucleic Acids Res | 2023 | 36629274 | PubTator, text mining | PubMed |
| First Cases of Spinocerebellar Ataxia 42 in Two Korean Families. | J Mov Disord | 2023 | 36628426 | PubTator, text mining | PubMed |
| Lymphoid clonal hematopoiesis: implications for malignancy, immunity, and treatment. | Blood Cancer J | 2023 | 36599826 | PubTator, text mining | PubMed |
| Tissue fluidification promotes a cGAS-STING cytosolic DNA response in invasive breast cancer. | Nat Mater | 2023 | 36581770 | PubTator, text mining | PubMed |
| High diagnostic yield of targeted next-generation sequencing panel as a first-tier molecular test for the patients with myopathy or muscular dystrophy. | Ann Hum Genet | 2023 | 36575883 | PubTator, text mining | PubMed |
| SYNE1-ataxia: clinicopathologic features of an autopsied patient with novel compound heterozygous mutations. | J Neuropathol Exp Neurol | 2023 | 36525394 | PubTator, text mining | PubMed |
| Molecular Subtypes of Head and Neck Cancer in Patients of African Ancestry. | Clin Cancer Res | 2023 | 36508165 | PubTator, text mining | PubMed |
| Trio-based exome sequencing broaden the genetic spectrum in keratoconus. | Exp Eye Res | 2023 | 36502923 | PubTator, text mining | PubMed |
| Comprehensive transcriptomic profiling and mutational landscape of primary gastric linitis plastica. | Gastric Cancer | 2023 | 36450891 | PubTator, text mining | PubMed |
| Early onset hereditary neuronopathies: an update on non-5q motor neuron diseases. | Brain | 2023 | 36445400 | PubTator, text mining | PubMed |
| Genomic signatures reveal selection in Lingxian white goose. | Poult Sci | 2023 | 36402042 | PubTator, text mining | PubMed |
| T cell-inflamed gene expression profile is associated with favorable disease-specific survival in non-hypermutated microsatellite-stable colorectal cancer patients. | Cancer Med | 2023 | 36341526 | PubTator, text mining | PubMed |
| Metabolic, fibrotic and splicing pathways are all altered in Emery-Dreifuss muscular dystrophy spectrum patients to differing degrees. | Hum Mol Genet | 2023 | 36282542 | PubTator, text mining | PubMed |
| Integrated tumor genomic and immune microenvironment analysis identifies predictive biomarkers associated with the efficacy of neoadjuvant therapy for triple-negative breast cancer. | Cancer Med | 2023 | 36271505 | PubTator, text mining | PubMed |
| TRIM67 drives tumorigenesis in oligodendrogliomas through Rho GTPase-dependent membrane blebbing. | Neuro Oncol | 2023 | 36215168 | PubTator, text mining | PubMed |
| Identification and validation of RB1 as an immune-related prognostic signature based on tumor mutation burdens in bladder cancer. | Anticancer Drugs | 2023 | 36206128 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/23345/papers?page=20